Nifty

:

11196.50

Sensex

:

37892.36

101.25 (0.91%)
204.45 (0.54%)

Login

Nifty
Sensex

:
:

11196.50
37892.36

101.25 (0.91%)
204.45 (0.54%)

IOL Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

86/99

BSE: 524164 | NSE: IOLCP

Watchlist

NSE BSE

744.65

04-Aug-2020

Open
High
Low
Previous Close

749.00
769.90
726.05
753.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1637863
12301.89
833.80
146.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,370.04
10.83
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,624.44
0.40%
4.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.04
34.37
33.36

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.66
105.16
32.01

PAT CAGR (%)

10 Years
5 Years
3 Years

37.19
-
270.08

P:E (Median)

8 Years
5 Years
3 Years

12.71
5.74
12.45

P:BV (Average)

8 Years
5 Years
3 Years

2.76
2.76
2.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.18
9.05
5.68

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 460.11 492.80 -6.63% 441.46 422.29 4.54% 511.25 478.29 6.89% 448.96 422.91 6.16%
Expenses 307.99 348.19 -11.55% 304.61 265.15 14.88% 351.75 342.78 2.62% 316.04 347.81 -9.13%
EBITDA 152.12 144.61 5.19% 136.85 157.14 -12.91% 159.50 135.51 17.70% 132.92 75.10 76.99%
EBIDTM 33.06% 29.34% 31.00% 37.21% 31.20% 28.33% 29.61% 17.76%
Other Income 5.80 3.32 74.70% 5.35 2.20 143.18% 3.96 0.85 365.88% 3.39 5.79 -41.45%
Interest 1.82 8.32 -78.12% 2.76 8.83 -68.74% 3.76 12.85 -70.74% 6.09 13.90 -56.19%
Depreciation 9.36 8.59 8.96% 9.36 7.99 17.15% 8.94 8.38 6.68% 8.84 8.16 8.33%
PBT 146.74 131.02 12.00% 130.08 142.52 -8.73% 150.76 115.13 30.95% 121.38 58.83 106.32%
Tax 19.20 45.70 -57.99% 39.82 40.87 -2.57% 52.75 32.89 60.38% 33.68 20.43 64.86%
PAT 127.54 85.32 49.48% 90.26 101.65 -11.21% 98.01 82.24 19.18% 87.70 38.40 128.39%
PATM 27.72% 17.31% 20.45% 24.07% 19.17% 17.19% 19.53% 9.08%
EPS 21.73 14.53 49.55% 15.38 17.32 -11.20% 16.70 14.01 19.20% 14.94 6.54 128.44%

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 1,861.78 1,685.33 983.30 710.65 580.42 384.73 563.50 481.51 470.68 389.41 349.42 Net Sales Growth 2.50% 71.40% 38.37% 22.44% 50.86% -31.72% 17.03% 2.30% 20.87% 11.44% Cost Of Goods Sold 1,032.39 1,047.25 695.28 477.40 416.20 279.34 369.54 300.23 299.77 241.90 239.67 Gross Profit 829.39 638.08 288.02 233.25 164.21 105.38 193.97 181.28 170.91 147.51 109.75 GP Margin 44.55% 37.86% 29.29% 32.82% 28.29% 27.39% 34.42% 37.65% 36.31% 37.88% 31.41% Total Expenditure 1,280.39 1,275.68 863.77 608.45 529.04 373.46 467.75 392.47 402.09 321.70 310.88 Power & Fuel Cost - 63.94 45.66 37.45 46.57 48.58 45.27 45.12 48.32 34.90 35.89 % Of Sales - 3.79% 4.64% 5.27% 8.02% 12.63% 8.03% 9.37% 10.27% 8.96% 10.27% Employee Cost - 78.43 56.10 43.18 35.13 24.72 27.08 22.08 20.14 17.01 11.24 % Of Sales - 4.65% 5.71% 6.08% 6.05% 6.43% 4.81% 4.59% 4.28% 4.37% 3.22% Manufacturing Exp. - 25.68 22.57 16.77 8.83 4.55 6.46 7.95 11.07 6.26 6.72 % Of Sales - 1.52% 2.30% 2.36% 1.52% 1.18% 1.15% 1.65% 2.35% 1.61% 1.92% General & Admin Exp. - 2.87 1.39 1.19 1.17 1.40 1.67 1.39 1.20 1.17 2.53 % Of Sales - 0.17% 0.14% 0.17% 0.20% 0.36% 0.30% 0.29% 0.25% 0.30% 0.72% Selling & Distn. Exp. - 46.61 33.73 20.81 12.81 6.39 11.27 0.00 0.00 0.00 14.09 % Of Sales - 2.77% 3.43% 2.93% 2.21% 1.66% 2.00% 0% 0% 0% 4.03% Miscellaneous Exp. - 10.90 9.04 11.65 8.33 8.48 6.47 15.70 21.58 20.46 14.09 % Of Sales - 0.65% 0.92% 1.64% 1.44% 2.20% 1.15% 3.26% 4.58% 5.25% 0.21% EBITDA 581.39 409.65 119.53 102.20 51.38 11.27 95.75 89.04 68.59 67.71 38.54 EBITDA Margin 31.23% 24.31% 12.16% 14.38% 8.85% 2.93% 16.99% 18.49% 14.57% 17.39% 11.03% Other Income 18.50 10.37 6.33 1.25 1.23 1.32 1.31 2.53 2.33 1.90 1.00 Interest 14.43 51.42 64.35 67.68 61.47 59.11 60.34 57.24 43.20 36.80 14.87 Depreciation 36.50 32.45 30.21 29.84 29.69 28.91 31.63 31.37 23.94 23.76 10.01 PBT 548.96 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 9.04 14.65 Tax 145.45 99.45 3.60 1.26 1.48 -8.79 1.78 1.37 -0.96 2.86 4.64 Tax Rate 26.50% 29.59% 11.50% 21.25% -3.84% 11.65% 35.04% 46.28% -25.26% 31.64% 31.67% PAT 403.51 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 6.18 10.02 PAT before Minority Interest 403.51 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 6.18 10.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.67% 14.04% 2.82% 0.66% -6.90% -17.32% 0.59% 0.33% 1.01% 1.59% 2.87% PAT Growth 31.18% 754.51% 493.15% - - - 107.55% -66.53% -23.14% -38.32% EPS 68.74 40.32 4.72 0.80 -6.82 -11.35 0.56 0.27 0.81 1.05 1.71

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 474.34 215.74 188.70 185.13 207.20 209.25 172.99 173.60 172.34 148.16 Share Capital 56.89 56.21 56.21 56.21 47.66 48.83 31.15 30.72 30.72 27.72 Total Reserves 408.13 159.53 132.49 128.92 153.56 160.42 141.84 142.45 139.52 116.24 Non-Current Liabilities 210.65 280.29 294.23 304.43 285.87 255.48 325.73 288.12 249.89 276.31 Secured Loans 189.88 236.16 262.37 283.25 253.84 163.91 202.96 198.26 179.76 251.56 Unsecured Loans 0.00 21.96 22.61 18.62 23.26 56.50 83.88 71.63 55.42 17.56 Long Term Provisions 4.59 2.04 1.50 1.18 0.30 0.30 0.13 0.12 0.33 0.00 Current Liabilities 324.38 350.97 327.67 282.92 208.54 276.82 228.54 225.83 180.64 83.75 Trade Payables 120.27 157.61 149.84 115.68 70.25 120.36 95.38 79.41 61.01 77.29 Other Current Liabilities 63.88 50.97 35.84 30.03 17.81 58.57 35.46 69.29 56.00 5.19 Short Term Borrowings 67.72 135.27 140.77 137.09 120.44 96.96 97.16 76.48 63.15 0.00 Short Term Provisions 72.51 7.12 1.22 0.13 0.04 0.94 0.54 0.65 0.48 1.27 Total Liabilities 1,009.37 847.00 810.60 772.48 701.61 741.55 727.26 687.55 602.87 508.22 Net Block 411.72 405.64 373.88 399.50 402.82 410.60 430.41 461.98 350.96 372.81 Gross Block 503.91 465.53 403.77 619.96 594.29 569.47 557.84 558.99 420.63 418.76 Accumulated Depreciation 92.19 59.89 29.89 220.47 191.47 158.86 127.42 97.01 69.67 45.96 Non Current Assets 453.82 416.02 395.94 415.63 418.12 460.38 475.91 487.70 424.74 373.39 Capital Work in Progress 27.02 6.95 21.26 4.31 4.21 33.06 31.51 12.38 56.80 0.59 Non Current Investment 0.00 0.00 0.05 0.04 0.04 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.78 1.26 0.38 9.01 10.75 13.08 11.92 11.01 15.12 0.00 Other Non Current Assets 7.30 2.17 0.37 2.77 0.30 3.63 2.07 2.34 1.86 0.00 Current Assets 555.55 430.98 414.66 356.86 283.49 281.17 251.35 199.85 178.12 134.82 Current Investments 0.06 0.06 0.05 0.05 0.01 0.00 0.00 0.00 0.00 0.00 Inventories 188.86 207.45 262.63 227.94 213.42 192.23 163.47 131.77 99.56 66.87 Sundry Debtors 199.16 146.14 112.77 87.26 32.67 49.26 35.82 21.59 31.14 30.11 Cash & Bank 29.60 17.32 16.81 11.94 12.70 11.45 12.39 8.70 18.08 6.60 Other Current Assets 137.87 3.22 3.61 2.89 24.68 28.25 39.66 37.80 29.36 31.25 Short Term Loans & Adv. 130.25 56.79 18.79 26.78 22.19 25.37 36.98 35.95 27.33 31.25 Net Current Assets 231.17 80.01 86.99 73.93 74.95 4.35 22.82 -25.97 -2.52 51.08 Total Assets 1,009.37 847.00 810.60 772.49 701.61 741.55 727.26 687.55 602.86 508.21

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 273.17 119.72 83.34 17.70 -46.96 78.40 53.19 54.91 23.64 31.42 PBT 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 9.04 14.65 Adjustment 82.35 91.64 95.92 83.92 81.73 86.38 83.25 63.48 57.02 22.12 Changes in Working Capital -77.64 3.14 -17.45 -27.67 -52.83 -12.31 -32.25 -11.39 -39.97 -3.44 Cash after chg. in Working capital 340.86 126.08 84.40 17.70 -46.54 79.15 53.96 55.89 26.09 33.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -67.69 -6.36 -1.06 0.00 -0.42 -0.75 -0.76 -0.98 -2.44 -1.91 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -63.04 -50.38 -22.78 -27.37 -4.79 -12.12 -17.97 -86.88 -69.33 -66.94 Net Fixed Assets -58.45 -47.45 199.24 -25.77 4.03 -13.18 -17.98 -93.94 -58.08 -72.73 Net Investments 0.00 0.04 -0.01 -0.04 -0.05 0.00 0.00 0.00 0.00 0.00 Others -4.59 -2.97 -222.01 -1.56 -8.77 1.06 0.01 7.06 -11.25 5.79 Cash from Financing Activity -197.46 -70.36 -59.78 9.27 49.69 -65.68 -31.80 23.05 59.02 35.43 Net Cash Inflow / Outflow 12.67 -1.02 0.78 -0.40 -2.07 0.60 3.42 -8.92 13.34 -0.09 Opening Cash & Equivalents 0.74 1.76 0.98 1.38 15.06 14.46 11.03 19.94 6.60 6.70 Closing Cash & Equivalent 13.41 0.74 1.76 0.98 12.99 15.06 14.46 11.03 19.94 6.60

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 81.74 38.38 33.57 32.94 42.22 65.67 64.24 65.39 64.25 61.17 ROA 25.50% 3.34% 0.59% -5.43% -9.24% 0.45% 0.22% 0.74% 1.11% 2.16% ROE 69.54% 13.70% 2.50% -20.72% -34.14% 1.85% 0.95% 2.85% 4.06% 8.47% ROCE 55.53% 15.03% 11.57% 3.68% -2.78% 11.48% 10.55% 8.72% 9.89% 7.61% Fixed Asset Turnover 3.48 2.30 1.51 1.06 0.73 1.11 0.96 1.03 1.01 1.29 Receivable days 37.39 47.21 47.21 33.98 35.12 24.85 19.63 19.04 26.46 27.14 Inventory Days 42.92 85.71 115.79 125.04 173.90 103.91 100.92 83.51 71.90 58.45 Payable days 37.74 62.92 46.31 3.40 9.79 8.96 18.14 19.56 50.02 74.16 Cash Conversion Cycle 42.57 69.99 116.69 155.61 199.24 119.80 102.41 82.98 48.35 11.43 Total Debt/Equity 0.61 1.96 2.37 2.44 1.99 1.71 2.31 2.28 1.98 1.87 Interest Cover 7.54 1.49 1.09 0.37 -0.28 1.08 1.05 1.09 1.25 1.99

Top Investors:

vasudeva commercials limited

vasudeva fuels private limited

vasudeva organics private limited

g consultants and fabricators ltd

morgan stanley asia (singapore) pte. - odi

Annual Reports:

News Update:

IOL Chemicals and Pharmaceuticals reports 49% rise in Q1 consolidated net profit
3rd Aug 2020, 15:33 PM

Total income of the company decreased 6.09% at Rs 465.91 crore for Q1FY21 as compared Rs 496.12
Read More
IOL Chemicals recognized as three star export house
29th Apr 2020, 11:00 AM

The certificate shall be valid for a period of five years
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback